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Background 
The detection of the new 
Coranavirus (CoV) causing agent 
of the severe acute respiratory 
syndrome (SARS) for diagnostic 
purposes is still a critical step in 
prevention of secondary hospital 
infections. In this respect the PCR 
for SARS diagnostic is the fastest 
and most sensitive method and 
was published very early after the 
description of the new pathogen 
by different groups. To evaluate 
the quality and sensitivity of the 
SARS PCR performed in diagnostic 
laboratories all over the world an 
external quality assurance (EQA) 
for SARS PCR was initiated by the 
WHO, the European Network for 
Diagnostics of "Imported" Viral 
Diseases (ENIVD) and the Robert 
Koch-Institut.
Methods 
Therefore 10 samples of inactivated SARS CoV strains 
isolated in Frankfurt and Hong 
Kong in different dilutions and 
negative controls were prepared. 
The freeze dried samples were 
send by mail to 62 different 
laboratories, in 37 countries in 
Europe and Israel (35), Asia (11), 
The Americas (11), Australia and 
New Zealand (4) and Africa (1). 
The results were returned by 
email or fax 1 week (13), 2 weeks 
(14), 3 weeks (6) and later (29) 
after receiving the material which 
does not mimic at all the possible 
speed of this fast method. But this 
was not considered in the 
evaluation of these first SARS EQA.
Results 
44 laboratories showed good or 
excellent results (26 = 100%, 18 
= 90%) and even the 14 
laboratories which archived only 
80% (10) or 70% (4) correct 
results are mostly lacking 
sensitivity. The results of the 
other 4 laboratories show basic 
problems in regard to sensitivity, 
specificity and consistency of 
results and must be overcome as 
soon as possible.
4 laboratories seem to have 
problems with the specificity 
finding a positive signal in 
negative samples. The different 
methods used for preparation of 
the SARS CoV genome and 
diagnostic PCR test procedure 
used by the participating 
laboratories will be discussed in 
more detail in the presentation.
Conclusion However, in contrast to previous 
EQAs for Ebola, Lassa and 
Orthopoxviruses the quality of 
PCR results was rather good which 
might be caused by the early 
publication and distribution of well 
developed PCR methods. 
An EQA for evaluation of SARS 
specific serology is still ongoing, 
first results will be available 
beginning of April 2004. 
gms german medical science | The Portal of the Association of the Scientific Medical Societies in 
Germany | AWMF  DIMDI  ZB MED 